PIMA542021
Otlertuzumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542021-Each-of-1 | In Stock | ₹ 44,020.62 |
PIMA542021 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,020.62
GST (18%): ₹ 7,923.712
Total Price: ₹ 51,944.332
Antigen
Otlertuzumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
TRU-016
Immunogen
Human CD37/TSPAN26
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
ELISA
Concentration
1.69 mg/mL
Formulation
30mM histidine with 0.06% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Target Molecule
Chemical
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Otlertuzumab is a biosimilar that targets CD37
- The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family
- Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains
- The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility
- This encoded protein is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins
- It may play a role in T-cell-B-cell interactions
- Alternate splicing results in multiple transcript variants encoding different isoforms.
Compare Similar Items
Show Difference
Antigen: Otlertuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: TRU-016
Immunogen: Human CD37/TSPAN26
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: ELISA
Concentration: 1.69 mg/mL
Formulation: 30mM histidine with 0.06% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Target Molecule: Chemical
Antigen:
Otlertuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
TRU-016
Immunogen:
Human CD37/TSPAN26
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
ELISA
Concentration:
1.69 mg/mL
Formulation:
30mM histidine with 0.06% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Target Molecule:
Chemical
Antigen: Ontuxizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: MORAb-004
Immunogen: Human CD248
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: ELISA, SDS-Page
Concentration: 1.1 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Target Molecule: Chemical
Antigen:
Ontuxizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
MORAb-004
Immunogen:
Human CD248
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
ELISA, SDS-Page
Concentration:
1.1 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Target Molecule:
Chemical
Antigen: Denintuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: hBU12-491; huBU12; SGN-19A; SGN-CD19A
Immunogen: Human CD19
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: ELISA, SDS-Page
Concentration: 2.38 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Target Molecule: Chemical
Antigen:
Denintuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
hBU12-491; huBU12; SGN-19A; SGN-CD19A
Immunogen:
Human CD19
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
ELISA, SDS-Page
Concentration:
2.38 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Target Molecule:
Chemical
Antigen: Diridavumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: CR6261; CR-6261
Immunogen: Influenza A virus hemagglutinin HA2 subunit from various strains
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Applications: ELISA, SDS-Page
Concentration: 1.41 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Target Molecule: Chemical
Antigen:
Diridavumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
CR6261; CR-6261
Immunogen:
Influenza A virus hemagglutinin HA2 subunit from various strains
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Applications:
ELISA, SDS-Page
Concentration:
1.41 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Target Molecule:
Chemical